Modulation of connective tissue growth factor and activin receptor 2B function in cardiac hypertrophy and fibrosis
Thesis event information
Date and time of the thesis defence
Place of the thesis defence
Leena Palotie auditorium 101A
Topic of the dissertation
Modulation of connective tissue growth factor and activin receptor 2B function in cardiac hypertrophy and fibrosis
Doctoral candidate
Master of Science Zoltan Szabo
Faculty and unit
University of Oulu Graduate School, Faculty of Medicine, Research Unit of Biomedicine
Subject of study
Biomedicine
Opponent
Professor Antti Saraste, Heart Center, Turku University Hospital
Custos
Professor Risto Kerkelä, University of Oulu, Faculty of Medicine, Research Unit of Biomedicine
MODULATION OF CONNECTIVE TISSUE GROWTH FACTOR AND ACTIVIN RECEPTOR 2B FUNCTION IN CARDIAC HYPERTROPHY AND FIBROSIS
The increase of cardiac hemodynamic load that requires increased mechanical performance drives adaptation of the heart to maintain cardiac function. Modification of protein synthesis in cardiomyocytes allows the cells to adapt to the increased load. Cardiomyocyte hypertrophy and activation of cardiac fibroblasts over the long term is maladaptive and leads to heart failure (HF). Understanding the complex and converging pathways regulating cardiac remodeling is a major challenge, but it may allow for opportunities to develop new therapies, new medicines and provide new hope for people with these life-threatening diseases.
Last updated: 1.3.2023